Encinitas, CA, United States of America

Terrence F Meehan

This inventor holds 2 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Terrence F Meehan. Retrieved from https://idiyas.com/inventor/terrence-f-meehan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Terrence F Meehan

Introduction

Terrence F Meehan is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment and prevention of multiple sclerosis. With a total of 2 patents, Meehan's work is recognized for its potential impact on patient care.

Latest Patents

Meehan's latest patents focus on the use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis. The methods involve administering an effective amount of calcitonin, calcitonin-like peptides, or calcitonin mimetics to patients. Additionally, he explores the use of 1,25-dihydroxyvitamin D analogs in combination with these treatments, enhancing their effectiveness.

Career Highlights

Terrence F Meehan is associated with the Wisconsin Alumni Research Foundation, where he continues to innovate and develop new therapeutic methods. His dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Meehan has collaborated with esteemed colleagues such as Hector Floyd Deluca and Bryan R Becklund. These partnerships have fostered a collaborative environment that enhances the quality and scope of his research.

Conclusion

Terrence F Meehan's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving patient outcomes. His work in treating multiple sclerosis is paving the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…